Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?
The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly a...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1980 |
| id |
doaj-9189a32a5840477a9b8f3be8d55be7cd |
|---|---|
| record_format |
Article |
| spelling |
doaj-9189a32a5840477a9b8f3be8d55be7cd2021-07-28T13:50:53Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-12-0110611212310.15829/1728-8800-2011-6-112-1231692Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?I. S. Yavelov0Russian State Medical UniversityThe review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly age, heparin medication change, or abnormal body weight), when the optimal balance between effectiveness and safety requires modifying the standard treatment protocols.https://cardiovascular.elpub.ru/jour/article/view/1980acute coronary syndromevenous thromboembolismatrial fibrillationenoxaparin |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
I. S. Yavelov |
| spellingShingle |
I. S. Yavelov Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? Кардиоваскулярная терапия и профилактика acute coronary syndrome venous thromboembolism atrial fibrillation enoxaparin |
| author_facet |
I. S. Yavelov |
| author_sort |
I. S. Yavelov |
| title |
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| title_short |
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| title_full |
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| title_fullStr |
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| title_full_unstemmed |
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| title_sort |
enoxaparin in cardiovascular disease: how to improve effectiveness and safety? |
| publisher |
«SILICEA-POLIGRAF» LLC |
| series |
Кардиоваскулярная терапия и профилактика |
| issn |
1728-8800 2619-0125 |
| publishDate |
2011-12-01 |
| description |
The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly age, heparin medication change, or abnormal body weight), when the optimal balance between effectiveness and safety requires modifying the standard treatment protocols. |
| topic |
acute coronary syndrome venous thromboembolism atrial fibrillation enoxaparin |
| url |
https://cardiovascular.elpub.ru/jour/article/view/1980 |
| work_keys_str_mv |
AT isyavelov enoxaparinincardiovasculardiseasehowtoimproveeffectivenessandsafety |
| _version_ |
1721271139997581312 |